Caliper Gets Remaining Compounds for ToxCast Screening

The firm said that the screening effort will likely push its revenue to the top end of its revenue guidance range for the fourth quarter and year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories